Shanghai Kehua Bio-Engineering Co.,Ltd - Laporan Laba Rugi (TTM)

Shanghai Kehua Bio-Engineering Co.,Ltd
CN ˙ SZSE
CN¥ 6.88 ↑0.16 (2.38%)
2025-09-08
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai Kehua Bio-Engineering Co.,Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 3,215 4,155 5,072 5,095 5,316 4,854 3,822 3,357 6,509 6,970 7,383 7,463 3,491 2,428 2,038 1,940 1,874 1,759 1,704
Change (%) 29.25 22.06 0.45 4.33 -8.68 -21.27 -12.15 93.89 7.07 5.92 1.10 -53.22 -30.45 -16.06 -4.81 -3.40 -6.13 -3.15
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,503 1,775 2,063 2,113 2,220 2,208 1,878 1,705 2,959 3,405 3,612 3,674 2,150 1,483 1,298 1,263 1,244 1,247 1,233
Change (%) 18.09 16.27 2.39 5.08 -0.56 -14.94 -9.22 73.58 15.08 6.07 1.71 -41.49 -30.99 -12.52 -2.70 -1.46 0.24 -1.13
% of Revenue 46.74 42.71 40.68 41.47 41.76 45.48 49.14 50.78 45.46 48.86 48.93 49.23 61.57 61.09 63.67 65.08 66.40 70.90 72.38
Gross Operating Profit 1,712 2,381 3,009 2,982 3,096 2,647 1,944 1,652 3,550 3,564 3,770 3,789 1,342 945 741 677 630 512 471
Change (%) 39.06 26.37 -0.87 3.80 -14.50 -26.56 -14.98 114.84 0.40 5.77 0.50 -64.59 -29.58 -21.61 -8.52 -7.03 -18.71 -8.08
% of Revenue 53.26 57.29 59.32 58.53 58.24 54.52 50.86 49.22 54.54 51.14 51.07 50.77 38.43 38.91 36.33 34.92 33.60 29.10 27.62
SG&A 768 846 921 905 961 824 730 654 913 1,315 1,402 1,496 1,176 886 848 770 762 958 943
Change (%) 10.11 8.80 -1.69 6.16 -14.25 -11.43 -10.40 39.57 44.10 6.63 6.69 -21.39 -24.71 -4.20 -9.27 -0.95 25.64 -1.52
% of Revenue 23.90 20.36 18.15 17.76 18.08 16.97 19.10 19.48 14.02 18.87 18.99 20.05 33.69 36.47 41.62 39.67 40.68 54.45 55.36
R&D 106 147 157 153 163 148 144 138 218 250 293 334 279 241 223 210 203 199 195
Change (%) 38.00 6.92 -2.44 6.14 -8.72 -2.85 -4.28 57.73 15.03 17.03 13.94 -16.45 -13.51 -7.70 -5.71 -3.46 -2.03 -1.60
% of Revenue 3.31 3.54 3.10 3.01 3.06 3.06 3.77 4.11 3.35 3.59 3.97 4.48 7.99 9.94 10.93 10.83 10.82 11.29 11.47
OpEx 2,394 2,777 3,162 3,193 3,349 3,186 2,752 2,494 4,064 4,853 5,182 5,351 3,472 2,569 2,328 2,233 2,213 2,414 2,388
Change (%) 16.00 13.83 0.99 4.89 -4.86 -13.64 -9.38 62.98 19.41 6.78 3.25 -35.11 -26.01 -9.39 -4.07 -0.89 9.06 -1.07
% of Revenue 74.48 66.84 62.33 62.67 63.00 65.64 72.00 74.27 62.43 69.63 70.20 71.69 99.45 105.81 114.21 115.11 118.10 137.22 140.16
Operating Income 821 1,378 1,911 1,902 1,967 1,668 1,070 864 2,445 2,117 2,200 2,113 19 -141 -290 -293 -339 -655 -684
Change (%) 67.92 38.65 -0.44 3.40 -15.18 -35.86 -19.28 183.11 -13.43 3.94 -3.98 -99.09 -829.70 105.48 1.20 15.75 92.99 4.51
% of Revenue 25.52 33.16 37.67 37.33 37.00 34.36 28.00 25.73 37.57 30.37 29.80 28.31 0.55 -5.80 -14.21 -15.11 -18.10 -37.22 -40.16
Interest Expense -31 -35 -40 -41 -40 -40 -43 -39 -41 -40 -37 -42 -43 -44 -45 -47 -47 -42 -36
Change (%) 11.24 13.94 3.92 -2.50 -0.50 6.94 -8.28 2.87 -1.10 -7.17 13.35 2.87 0.88 3.63 2.74 0.42 -9.70 -14.09
% of Revenue -0.98 -0.84 -0.79 -0.81 -0.76 -0.83 -1.12 -1.17 -0.62 -0.57 -0.50 -0.56 -1.24 -1.80 -2.22 -2.40 -2.50 -2.40 -2.13
Net Income 396 675 968 962 1,003 850 530 418 1,313 972 1,004 946 -240 -234 -318 -308 -336 -641 -665
Change (%) 70.55 43.27 -0.60 4.25 -15.18 -37.62 -21.24 214.36 -26.02 3.34 -5.75 -125.41 -2.67 35.72 -3.15 9.30 90.54 3.81
% of Revenue 12.32 16.25 19.08 18.88 18.86 17.52 13.88 12.44 20.18 13.94 13.60 12.68 -6.89 -9.64 -15.58 -15.86 -17.94 -36.41 -39.03

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista